BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11933209)

  • 21. A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome.
    Little S; Hanks S; King-Underwood L; Picton S; Cullinane C; Rapley E; Rahman N; Pritchard-Jones K
    Pediatr Nephrol; 2005 Jan; 20(1):81-5. PubMed ID: 15503171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonad development in Drash and Frasier syndromes depends on WT1 mutations.
    Jaubert F; Vasiliu V; Patey-Mariaud de Serre N; Auber F; Jeanpierre C; Gubler MC; Nihoul-Fékété C; Fellous M
    Arkh Patol; 2003; 65(2):40-4. PubMed ID: 15357247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical and pathological features of Denys-Drash syndrome: report of 3 cases].
    Wang HY; Sun LZ; Yue ZH; Yang J; Jiang XY; Mo Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):855-8. PubMed ID: 23302619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.
    Bruening W; Bardeesy N; Silverman BL; Cohn RA; Machin GA; Aronson AJ; Housman D; Pelletier J
    Nat Genet; 1992 May; 1(2):144-8. PubMed ID: 1302008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of Denys-Drash syndrome with prophylactic bilateral nephrectomy].
    Yamamoto K; Santo Y; Satomura K
    Nihon Jinzo Gakkai Shi; 2003; 45(1):42-6. PubMed ID: 12680320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inherited WT1 mutation in Denys-Drash syndrome.
    Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
    Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Embryonal hyperplasia of Bowman's capsular epithelium in patients with WT1 mutations.
    Fukuzawa R; Eccles MR; Ikeda M; Hata J
    Pediatr Nephrol; 2003 Jan; 18(1):9-13. PubMed ID: 12488983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
    Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
    J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A familial WT1 mutation associated with incomplete Denys-Drash syndrome.
    Zhu C; Zhao F; Zhang W; Wu H; Chen Y; Ding G; Zhang A; Huang S
    Eur J Pediatr; 2013 Oct; 172(10):1357-62. PubMed ID: 23715653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Denys-Drash syndrome].
    Kohsaka T; Tagawa M; Yamada M
    Nihon Rinsho; 2006 Sep; Suppl 3():457-64. PubMed ID: 17022587
    [No Abstract]   [Full Text] [Related]  

  • 31. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report.
    Alge JL; Wenderfer SE; Hicks J; Bekheirnia MR; Schady DA; Kain JS; Braun MC
    BMC Nephrol; 2017 Jul; 18(1):243. PubMed ID: 28720077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications.
    Hashimoto H; Zhang X; Zheng Y; Wilson GG; Cheng X
    Nucleic Acids Res; 2016 Dec; 44(21):10165-10176. PubMed ID: 27596598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.
    Wang D; Horton JR; Zheng Y; Blumenthal RM; Zhang X; Cheng X
    Nucleic Acids Res; 2018 May; 46(8):3864-3877. PubMed ID: 29294058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy.
    Patel PR; Pappas J; Arva NC; Franklin B; Brar PC
    J Pediatr Endocrinol Metab; 2013; 26(9-10):971-4. PubMed ID: 23729537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
    Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
    Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
    Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
    Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refining the Diagnosis of Congenital Nephrotic Syndrome on Long-term Stored Tissue: c.1097G>A (p.(Arg366His)) WT1 Mutation Causing Denys Drash Syndrome.
    Hillen LM; Kamsteeg EJ; Schoots J; Tiebosch AT; Speel EJ; Roemen GM; Peutz-Koostra CJ; Stumpel CT
    Fetal Pediatr Pathol; 2016; 35(2):112-9. PubMed ID: 26882358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report].
    Wasilewska A; Zoch-Zwierz W; Tenderenda E; Rybi-Szumińska A; Kołodziejczyk Z
    Pol Merkur Lekarski; 2009 Jun; 26(156):642-4. PubMed ID: 19711733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Denys-Drash syndrome.
    Kucinskas L; Rudaitis S; Pundziene B; Just W
    Medicina (Kaunas); 2005; 41(2):132-4. PubMed ID: 15758579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.